tosylate (Darenthin, Burroughs Wellcome), is one of the series of benzyl quaternary ammonium compounds which blocks selectively the peripheral sympathetic nervous system without antagonizing the effects of epinephrine. This block occurs without depression of the parasympathetic or central nervous system. 1 ' 2 Its effect on the pulmonary circulation has not hitherto been investigated.
pulmonary (Cv ) arterial blood 3 and total hemoglobin 4 were determined speetrophotometrically. Expired nir (V E ) was collected for 1% to 2y 2 minutes in Douglas bags; their composition was analyzed by the Haldane method. Carbon dioxide content and pH were measured in the arterial blood of three animals. Their arterial CO 2 tension (Pa ) and alveolar ventilation (V J were calcu-C02 lated as described elsewhere. 5 Pulmonary arterial (P p a .) and systemic arterial (Pf.a.) pressures were measured by transducers and recorded on a Sanborn multichannel directwriting oscillograph. In two animals pulmonary arterial wedge pressure (P p . n . w .) a n d right ventricular pressure ( P r v ) were recorded simultaneously. A point 10 cm. above the back of the From the Department of Medicine, University of Sydney, Sydney, Australia.
Beceived for publication August 11, 1960. supine animals was used for reference level. Pressures were determined before and after the collection of expired air. Blood samples were taken in the midperiod of collection of expired air. was estimated by subtracting 0.60 volume per cent from the oxygen-carrying capacity of the arterial blood. 8 Total pulmonary (R|,,,im) and systemic (R sys t) resistances were calculated by the usual formulas and expressed in dynes/sec./cm.~5. Flows, resistances, and ventilated volumes are expressed on basis of one square meter of body surface area.
After a control period, 10 mg./Kg. bretylium were slowly injected into the pulmonary artery. Twenty-five minutes later all measurements were repeated. In two animals 100 per cent oxygen breathing was commenced subsequently for 10 minutes.
Results Results are shown in table 1. The slight, not statistically significant, increase in V E and V t may be coincident to a significant rise in Q s (0.02 < P < 0.05) and the resulting hypoxemia. The slight increase in Q and the equally small fall in Pf a resulted in a decrease in R s y s t of questionable statistical significance (0.05 < P < 0.10). A rise in P p a . w . has also occurred in both cases investigated ( fig. 1 ) . Alveolar oxygen tension (P A ) was calculated in three animals (nos. 116, 121, and 123). I t was normal during the control period and increased slightly after the administration of bretylium. The inhalation of 100 per cent oxygen resulted in a fall in P p n . and P p . a . w . in both animals ("=• •*•'• Discussion It is not without precedent that a systemic hypotensive agent should act as a pressor substance in the pulmonary circulation: Apresoline has a similar effect. 0 ' 10 This action of bretylium is apparently unrelated to its sym-patholytic properties. Other adrener'gic neurone blocking agents, e.g., Hydergine 11 or Dibenamine, 12 fail to increase P p . a ..
The simultaneous rise in P p . a .w. indicates that bretylium-induced pulmonary hypertension has a preeapillary and postcapillary component. The rapid return of both pressures to normal during oxygen breathing appear to suggest that the rise in pressure was caused by a constriction or increase in tone of the arterioles and venules.
The increase in Q s is reminiscent of that following the administration of aminophylline, norepinephrine, 13 and acetylcholine. 14 No attempt was made to investigate its mechanism.
Pulmonary hypertension in bretyliumtreated sheep was coincident to hypoxemia and reversed by oxygen breathing. This indicates the necessity to assess the possible role of hypoxia.
Hypoxemia was shown to increase P p . a . in dogs in the presence of normal P A provided the fall in S a exceeded 10 per cent. 15 Mean in Pp. a ... As the most potent pulmonary vasodilator, oxygen is capable of abolishing several types of pulmonary hypertension etiologically unrelated to hypoxia. 16~ls It appears, therefore, unlikely that hypoxemia would be a major factor in the genesis of the mild pulmonary hypertension induced by bretylium. Table 1 Cardio pulmonary = control period; D = 25 minutes following the significance of changes is described in text.
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Summary
In a dose sufficient to produce a mild systemic hypotension, bretylium increases pulmonary arterial pressure and venous admixture in the experimental animal. The clinical significance of these side effects appears to deserve some consideration.
